Alcohol septal ablation complicated by complete heart block and permanent pacemaker failure

Catheterization and Cardiovascular Interventions

Volumn 58, Issue 2, 2003, Pages 189-193

  Valettas, Nicholas ^a   Rho, Robert ^a   Beshai, John ^a   Lloyd, Caroline T ^a   Ross, Heather M ^a   Kocovic, Dusan ^a   Herrmann, Howard C ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Complete heart block; Hypertrophic cardiomyopathy; Septal ablation

Indexed keywords

ARTICLE; ARTIFICIAL HEART PACEMAKER; CASE REPORT; CATHETER ABLATION; CLINICAL FEATURE; COMPLETE HEART BLOCK; DEFIBRILLATOR; DISEASE COURSE; HEART CATHETERIZATION; HEART PACING; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; MALE; PROPHYLAXIS; SINUS NODE; SURGICAL TECHNIQUE; TREATMENT OUTCOME; TREATMENT PLANNING;

ADULT; CARDIOMYOPATHY, HYPERTROPHIC; CATHETER ABLATION; ELECTROCARDIOGRAPHY; EQUIPMENT FAILURE; ETHANOL; HEART BLOCK; HUMANS; MALE; PACEMAKER, ARTIFICIAL;

EID: 0037309661     PISSN: 15221946     EISSN: None     Source Type: Journal    
DOI: 10.1002/ccd.10412     Document Type: Article

References (15)

1. Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA 2002;287:1308-1320.
2. Robbins RC, Stinson EB. Long-term results of left ventricular myotomy and myectomy for obstructive hypertrophic cardiomyopathy. J Thorac Cardiovasc Surg 1996;111:586-594.
3. McCully RB, Nishimura RA, Tajik AJ, Schaff HV, Danielson GK. Extent of clinical improvement after surgical treatment of hypertrophic obstructive cardiomyopathy. Circulation 1996;94: 467-471.
4. Sigwart U. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet 1995;346:211-214.
5. Lakkis NM, Nagueh SF, Dunn JK, Killip D, Spencer WH. Non-surgical septal reduction therapy for hypertrophic obstructive cardiomyopathy: one-year follow-up. J Am Coll Cardiol 2000;36: 852-855.
6. Seggewiss H, Gleichmann U, Faber L, Fassbender D, Schmidt HK, Strick S. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients. J Am Coll Cardiol 1998;31:252-258.
7. Mazur W, Nagueh SF, Lakkis NM, Dunn JK, Middleton KJ, Killip D, Roberts R, Spencer WH. Regression of left ventricular hypertrophy after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. Circulation 2001;103:1492-1496.
8. Maron BJ. Role of alcohol septal ablation in treatment of obstructive hypertrophic cardiomyopathy. Lancet 2000;355:425-426.
9. Lakkis NM, Nagueh SF, Kleiman NS, Killip D, He Z-X, Verani MS, Roberts R, Spencer WH. Echocardiography-guided ethanol septal reduction for hypertrophic obstructive cardiomyopathy. Circulation 1998;98:1750-1755.
10. Ellenbogen KA, Kay GN, Wilkoff BL. Clinical cardiac pacing and defibrillation, 2nd ed. Philadephia: W.B. Saunders; 2000. p 53-67.
11. Sutton PM, Taggart P, Opthof T, et al. Repolarisation and refractoriness during early ischaemia in humans. Heart 2000;84:365-369.
12. Kleber AG, Riegger CB, Janse MJ. Electrical uncoupling and increase of extracellular resistance after induction of ischemia in isolated, arterially perfused rabbit pappilary muscle. Circ Res 1987;61:271-279.
13. 2+, intracellular electrical uncoupling, and mechanical activity in ischemic rabbit pappilary muscle: effects of preconditioning and metabolic blockade. Circ Res 1996;79:237-246.
14. Little T. External cardiac pacing in right ventricular infarction. Ann Emerg Med 1988;17:640-642.
15. Mittal SR, Mahar MS, Gokhroo RK. Transvenous pacing in the presence of acute right ventricular infarction. Int J Cardiol 1992: 34:100-101.